Drug Use Investigation for IMURAN (Azathioprine) Tablet (Hepatic Transplantation)

NCT01390766 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 41

Last updated 2012-09-03

No results posted yet for this study

Summary

This post-marketing surveillance (PMS) study is designed to investigate the efficacy and safety of azathioprine tablets in Japanese subjects whom liver transplantation is performed.

Conditions

Interventions

DRUG

Azathioprine

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-08-31
Primary Completion
2011-05-31
Completion
2011-05-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01390766 on ClinicalTrials.gov